On April 29, 2019, CTS will begin performing Donor-Screen HLA® Class I and II testing on the Stratec Biomedical AG Gemini. This instrumentation change is necessary as Bio-Rad is discontinuing service on our existing QuickStep instrumentation.
Although the Immucor assay and sample requirements will remain the same, the package insert has been modified to state the assay is specific to the Stratec Gemini instrument. The new package insert, assay history list, and platform history list will be available on the CTS website on 04/29/19.
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
After a thorough and comprehensive review of proposals received from suppliers of viral marker testi...
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
We are very excited to launch our new website! Please take a few moments to click around and explore...
Seasonal monitoring of epidemic triggers for West Nile Virus (WNV) NAT tested donations will begin J...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...